Clinic alleges “market-allocation” for erectile dysfunction treatment
Two rival providers of erectile dysfunction treatments have allocated the market for their services through an anticompetitive licensing settlement and baseless patent infringement claims, a medical clinic has alleged.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10